Caprock Group LLC Invests $329,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Caprock Group LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 552 shares of the biotechnology company’s stock, valued at approximately $329,000.

Other hedge funds also recently modified their holdings of the company. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the 4th quarter worth about $40,000. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. Versant Capital Management Inc boosted its holdings in Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after purchasing an additional 95 shares during the last quarter. Berbice Capital Management LLC bought a new position in Axon Enterprise in the fourth quarter valued at $59,000. Finally, Brooklyn Investment Group bought a new position in Axon Enterprise in the third quarter valued at $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on AXON. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, JMP Securities boosted their target price on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Trading Up 2.7 %

Shares of AXON stock opened at $680.52 on Thursday. The firm has a 50 day moving average price of $621.94 and a two-hundred day moving average price of $490.00. The company has a market capitalization of $51.89 billion, a PE ratio of 175.85, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 12-month low of $255.58 and a 12-month high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insiders Place Their Bets

In other news, President Joshua Isner sold 20,000 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 in the last 90 days. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.